Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$84.3 - $94.31 $954,107 - $1.07 Million
-11,318 Reduced 10.35%
98,062 $9.06 Million
Q1 2024

May 08, 2024

SELL
$72.54 - $95.56 $618,983 - $815,413
-8,533 Reduced 7.24%
109,380 $10.5 Million
Q4 2023

Feb 08, 2024

SELL
$61.71 - $77.76 $1.02 Million - $1.29 Million
-16,594 Reduced 12.34%
117,913 $8.99 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $162,808 - $219,443
-2,350 Reduced 1.72%
134,507 $9.32 Million
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $3.54 Million - $4.11 Million
-43,523 Reduced 24.13%
136,857 $12.9 Million
Q1 2023

May 11, 2023

SELL
$74.26 - $84.51 $5.88 Million - $6.69 Million
-79,209 Reduced 30.51%
180,380 $14.9 Million
Q4 2022

Feb 09, 2023

SELL
$68.3 - $87.44 $2.76 Million - $3.54 Million
-40,433 Reduced 13.48%
259,589 $19.4 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $5.57 Million - $7.26 Million
-67,637 Reduced 18.4%
300,022 $24.8 Million
Q2 2022

Aug 12, 2022

SELL
$86.5 - $128.27 $132 Million - $196 Million
-1,526,984 Reduced 80.59%
367,659 $35 Million
Q1 2022

May 13, 2022

SELL
$101.96 - $128.34 $6.02 Million - $7.58 Million
-59,027 Reduced 3.02%
1,894,643 $223 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $120 Million - $148 Million
-1,132,598 Reduced 36.7%
1,953,670 $253 Million
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $38.6 Million - $46.1 Million
-375,184 Reduced 10.84%
3,086,268 $349 Million
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $42.8 Million - $53.5 Million
-510,646 Reduced 12.86%
3,461,452 $359 Million
Q1 2021

May 13, 2021

SELL
$78.68 - $90.67 $225 Million - $259 Million
-2,860,772 Reduced 41.87%
3,972,098 $332 Million
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $58.5 Million - $74.4 Million
816,051 Added 13.56%
6,832,870 $623 Million
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $404 Million - $526 Million
6,016,819 New
6,016,819 $480 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Jackson Square Partners, LLC Portfolio

Follow Jackson Square Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Partners, LLC with notifications on news.